Ultragenyx Pharmaceutical Statistics
Total Valuation
RARE has a market cap or net worth of $3.00 billion. The enterprise value is $3.42 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RARE has 96.30 million shares outstanding. The number of shares has increased by 12.26% in one year.
| Current Share Class | 96.30M |
| Shares Outstanding | 96.30M |
| Shares Change (YoY) | +12.26% |
| Shares Change (QoQ) | +1.33% |
| Owned by Insiders (%) | 3.50% |
| Owned by Institutions (%) | 101.60% |
| Float | 92.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.93 |
| Forward PS | 4.01 |
| PB Ratio | 185.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 53.41.
| Current Ratio | 1.89 |
| Quick Ratio | 1.59 |
| Debt / Equity | 53.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.37 |
Financial Efficiency
Return on equity (ROE) is -313.43% and return on invested capital (ROIC) is -31.69%.
| Return on Equity (ROE) | -313.43% |
| Return on Assets (ROA) | -24.92% |
| Return on Invested Capital (ROIC) | -31.69% |
| Return on Capital Employed (ROCE) | -63.97% |
| Revenue Per Employee | $487,325 |
| Profits Per Employee | -$448,090 |
| Employee Count | 1,294 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 16.63 |
Taxes
In the past 12 months, RARE has paid $3.11 million in taxes.
| Income Tax | 3.11M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.91% in the last 52 weeks. The beta is 0.16, so RARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -30.91% |
| 50-Day Moving Average | 31.69 |
| 200-Day Moving Average | 34.38 |
| Relative Strength Index (RSI) | 42.87 |
| Average Volume (20 Days) | 1,333,680 |
Short Selling Information
The latest short interest is 7.14 million, so 7.42% of the outstanding shares have been sold short.
| Short Interest | 7.14M |
| Short Previous Month | 8.69M |
| Short % of Shares Out | 7.42% |
| Short % of Float | 7.69% |
| Short Ratio (days to cover) | 5.26 |
Income Statement
In the last 12 months, RARE had revenue of $630.60 million and -$579.83 million in losses. Loss per share was -$5.94.
| Revenue | 630.60M |
| Gross Profit | -163.82M |
| Operating Income | -544.00M |
| Pretax Income | -576.72M |
| Net Income | -579.83M |
| EBITDA | -508.70M |
| EBIT | -544.00M |
| Loss Per Share | -$5.94 |
Full Income StatementBalance Sheet
The company has $425.25 million in cash and $863.11 million in debt, giving a net cash position of -$415.80 million or -$4.32 per share.
| Cash & Cash Equivalents | 425.25M |
| Total Debt | 863.11M |
| Net Cash | -415.80M |
| Net Cash Per Share | -$4.32 |
| Equity (Book Value) | 16.16M |
| Book Value Per Share | 0.10 |
| Working Capital | 303.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$445.67 million and capital expenditures -$5.72 million, giving a free cash flow of -$451.39 million.
| Operating Cash Flow | -445.67M |
| Capital Expenditures | -5.72M |
| Free Cash Flow | -451.39M |
| FCF Per Share | -$4.69 |
Full Cash Flow StatementMargins
Gross margin is -25.98%, with operating and profit margins of -86.27% and -91.95%.
| Gross Margin | -25.98% |
| Operating Margin | -86.27% |
| Pretax Margin | -91.46% |
| Profit Margin | -91.95% |
| EBITDA Margin | -80.67% |
| EBIT Margin | -86.27% |
| FCF Margin | n/a |
Dividends & Yields
RARE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.26% |
| Shareholder Yield | -12.26% |
| Earnings Yield | -19.31% |
| FCF Yield | -15.03% |
Dividend DetailsAnalyst Forecast
The average price target for RARE is $87.71, which is 181.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $87.71 |
| Price Target Difference | 181.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 32.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RARE has an Altman Z-Score of -3.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.98 |
| Piotroski F-Score | 4 |
